Food reduces the oral bioavailability of propantheline bromide in healthy subjects. 1983

D K Moses, and B G Charles, and P J Ravenscroft, and I M Whyte

UI MeSH Term Description Entries
D011413 Propantheline A muscarinic antagonist used as an antispasmodic, in rhinitis, in urinary incontinence, and in the treatment of ulcers. At high doses it has nicotinic effects resulting in neuromuscular blocking. Pro-Banthine,Probanthine,Propantheline Bromide,Bromide, Propantheline,Pro Banthine
D005502 Food Substances taken in by the body to provide nourishment. Foods
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

D K Moses, and B G Charles, and P J Ravenscroft, and I M Whyte
January 1981, Urologia internationalis,
D K Moses, and B G Charles, and P J Ravenscroft, and I M Whyte
May 2012, International journal of clinical pharmacology and therapeutics,
D K Moses, and B G Charles, and P J Ravenscroft, and I M Whyte
January 1982, Journal of clinical pharmacology,
D K Moses, and B G Charles, and P J Ravenscroft, and I M Whyte
January 1984, Journal - Association of Official Analytical Chemists,
D K Moses, and B G Charles, and P J Ravenscroft, and I M Whyte
January 1996, American journal of nephrology,
D K Moses, and B G Charles, and P J Ravenscroft, and I M Whyte
January 2006, Arzneimittel-Forschung,
D K Moses, and B G Charles, and P J Ravenscroft, and I M Whyte
January 1998, European journal of drug metabolism and pharmacokinetics,
D K Moses, and B G Charles, and P J Ravenscroft, and I M Whyte
April 1983, Antimicrobial agents and chemotherapy,
D K Moses, and B G Charles, and P J Ravenscroft, and I M Whyte
February 1997, Environmental health perspectives,
D K Moses, and B G Charles, and P J Ravenscroft, and I M Whyte
August 2001, Journal of clinical pharmacology,
Copied contents to your clipboard!